Hong Kong Pharmaceuticals & Biotech Most Popular Stocks

Hansoh Pharmaceutical Group

Market Cap: HK$232.8b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Innovent Biologics

Market Cap: HK$150.8b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$146.0b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Akeso

Market Cap: HK$126.9b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$113.6b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Sino Biopharmaceutical

Market Cap: HK$102.9b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$102.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

RemeGen

Market Cap: HK$82.1b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

WuXi XDC Cayman

Market Cap: HK$77.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

3SBio

Market Cap: HK$59.6b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

Shanghai Henlius Biotech

Market Cap: HK$45.2b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$44.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Shanghai Junshi Biosciences

Market Cap: HK$43.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.

XtalPi Holdings

Market Cap: HK$41.1b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$39.1b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Simcere Pharmaceutical Group

Market Cap: HK$35.5b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

InSilico Medicine Cayman TopCo

Market Cap: HK$34.7b

Operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally.

China Medical System Holdings

Market Cap: HK$33.6b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

InnoCare Pharma

Market Cap: HK$30.3b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Shanghai Bao Pharmaceuticals

Market Cap: HK$30.0b

Operates as a clinical-stage biotechnology company.

TransThera Sciences (Nanjing)

Market Cap: HK$28.0b

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

Genscript Biotech

Market Cap: HK$27.6b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Duality Biotherapeutics

Market Cap: HK$25.8b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Sunshine Lake Pharma

Market Cap: HK$25.6b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

Grand Pharmaceutical Group

Market Cap: HK$23.1b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Keymed Biosciences

Market Cap: HK$21.9b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

United Laboratories International Holdings

Market Cap: HK$19.3b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Ascletis Pharma

Market Cap: HK$18.6b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

PegBio

Market Cap: HK$18.3b

A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.

Ascentage Pharma Group International

Market Cap: HK$18.1b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Nanjing Leads Biolabs

Market Cap: HK$17.7b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

Xuanzhu Biopharmaceutical

Market Cap: HK$16.1b

Engages in the development, industrialization, and commercialization of small-molecule chemical drugs and macromolecular biopharmaceuticals in China.

CStone Pharmaceuticals

Market Cap: HK$14.6b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.

GenFleet Therapeutics (Shanghai)

Market Cap: HK$14.5b

Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.

Fujian Haixi Pharmaceuticals

Market Cap: HK$14.5b

Manufactures and sells pharmaceutical drugs in China.

Consun Pharmaceutical Group

Market Cap: HK$13.9b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.